Dicalcium Phosphate Dihydrate.
Does double duty as a calcium/phosphorus source and a tablet filler. You get some minerals, but it's mostly here for manufacturing. Tablet binder and filler that also provides some calcium and phosphorus.
Reviewed March 2026
- Category
- Mineral
- Also filed under
- Provides calcium and phosphorusDoubles as effective tablet binder
What Dicalcium Phosphate Dihydrate is, and what it does.
- Does it work
- Functional filler with a mineral bonus. Not a primary calcium source.
- How much to take
- Not typically dosed as a standalone. Part of the tablet.
- Time to feel it
- There's no onset to feel. It needs stomach acid to dissolve, and what it adds shows up in your calcium and phosphorus intake totals rather than in a sensation.
- The first dose
- Day one passes quietly. It needs stomach acid to dissolve, and the calcium and phosphorus it releases join that day's intake rather than announcing themselves.
- With regular use
- Across weeks it adds a small, steady amount of calcium and phosphorus in the roughly one-to-one ratio bone mineral is built from. It registers in intake totals rather than as a sensation.
- How well tolerated
- Well tolerated. Requires stomach acid for dissolution.
- How it feels
- There's no sensation to it. What you notice is a tablet that presses cleanly and holds its shape, while the minerals it carries register in your intake totals.
- The overlooked benefit
- The two water molecules locked into the crystal are what make it press cleanly into a tablet, and they leave if it's dried too hot. That's why the drying step is specified.
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
- Effective calcium source
Questions people ask about Dicalcium Phosphate Dihydrate.
- Does this count as my calcium supplement?
- Not really. The amounts in tablets as a filler are usually too small for meaningful calcium supplementation.
- Is DCP a bad ingredient?
- No. It's a safe, functional excipient. The calcium is a minor bonus.
- Should I worry about phosphorus?
- Not from supplement amounts. Phosphorus is only a concern at very high dietary intakes for people with kidney disease.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Vitamin D increases intestinal uptake of both calcium and phosphate, the two ions this salt supplies. Absorption of the material depends heavily on vitamin D status.
K2 carboxylates osteocalcin and matrix Gla protein so calcium is bound into bone rather than deposited elsewhere. It gives the calcium phosphate load a destination.
Magnesium is required to activate vitamin D and sits in the bone mineral lattice with calcium and phosphate. A heavy calcium and phosphate load without magnesium leaves the mineral balance skewed.
Both calcium and phosphate lower non-heme iron absorption, calcium at the transporter and phosphate by forming poorly soluble complexes. Separating the doses is the usual formulation answer.
The bisglycinate chelate keeps iron shielded from phosphate precipitation and calcium competition better than simple salts. Where iron must share a tablet with calcium phosphate, the chelate is the form chosen.
A large calcium dose in the same serving reduces zinc uptake through shared divalent transport. Splitting them protects zinc status.
Dicalcium phosphate is poorly soluble at neutral pH and needs stomach acid to dissolve and release calcium. Low acidity leaves much of the dose unabsorbed.
Strontium and calcium compete for the same intestinal transport and the same bone mineral sites. Co-dosing lowers uptake of both, so they are given at different times.
Boron influences calcium and magnesium retention and vitamin D handling, and appears alongside calcium phosphate in bone formulas for that reason.
Dicalcium phosphate supplies phosphate already in inorganic form, so none of it depends on phytase activity. The calcium half of the salt is the point of friction: free calcium in the gut lumen forms poorly soluble complexes with phytate, which lowers the amount of substrate phytase can act on. Formulators who add both usually mind the total calcium load for that reason.
Inulin is fermented in the large bowel to short-chain fatty acids, which lowers luminal pH. Calcium salts are more soluble as pH falls, and more soluble calcium in the colon means more available for paracellular uptake. This is a plausible and partly measured route rather than a settled one, and it concerns a mineral-handling marker rather than a bone outcome.
Short-chain fructooligosaccharides ferment quickly in the proximal colon and acidify the lumen. Dicalcium phosphate that has not dissolved higher up encounters that lower pH and becomes more soluble. The effect described is on calcium solubility and apparent absorption, not on bone density.
Galactooligosaccharides are fermented by bifidobacteria to acids that increase the soluble fraction of calcium salts in the distal gut. Pairing them with a calcium phosphate source is a formulation logic used in infant and adult nutrition products. What is measured is mineral solubility and absorption fraction.
Both salts contribute elemental calcium, so the totals add up and should be counted together rather than separately. Carbonate needs gastric acid to release free calcium and is usually taken with food for that reason, while dicalcium phosphate dihydrate also brings a phosphate load with it. Fractional absorption of calcium falls as the single dose rises, so splitting a large combined total across the day is the usual practice.
Sodium and calcium share reabsorption handling in the renal tubule, so a higher sodium intake raises urinary calcium loss. A calcium phosphate supplement taken against a high-sodium background is therefore partly offset at the kidney. This is a balance point, not a reason to avoid either.
Caffeine produces a modest increase in urinary calcium excretion in the hours after intake. Against an adequate calcium intake the effect is small. Against a low one it matters more. The measurement is urinary calcium, a marker of handling, not a bone outcome.
Alkaline potassium salts reduce net acid load, and a lower acid load is associated with less urinary calcium excretion. That makes potassium intake part of the same calcium balance ledger as the supplemental dose. The relationship is measured on urinary markers and in association studies, so it is a modifier rather than a cause of any bone change.
Bicarbonate cuts two ways with a calcium phosphate salt. Systemically it lowers net acid load, which is associated with reduced urinary calcium excretion. In the stomach it raises pH, and calcium phosphate dissolves less readily as pH rises, so timing the two apart is the usual formulation answer.
High intakes of calcium and phosphate lower the apparent absorption of manganese, which shares divalent cation handling in the small intestine. The practical consequence shows up when a mineral blend carries a large calcium phosphate load and a small manganese one. Separating the doses is the standard workaround.
Psyllium forms a viscous gel that slows the mixing and dissolution of a mineral salt in the upper gut. That does not remove the calcium or the phosphate, it shifts where and how quickly they become available. Taking a bulk fibre and a mineral dose an hour or two apart avoids the question.
Lysine has been reported to increase intestinal calcium absorption and to reduce urinary calcium loss when taken with a calcium load. The work is small and the endpoint is mineral handling. It is a reasonable pairing to note, not a settled one.
Vitamin K1 is the cofactor for the carboxylase that adds calcium-binding glutamate residues to osteocalcin and other matrix proteins. Calcium and phosphate supply the mineral. Carboxylated matrix protein is part of how it is organised. The measured endpoint in most human work is carboxylation status, a marker, rather than a change in bone.
Silicon is involved in collagen matrix formation, the scaffold that calcium phosphate mineral is laid down on. Higher dietary silicon has been associated with bone mineral density in cohort analyses, which is an association and not a demonstrated cause. It sits alongside the mineral supply rather than replacing any part of it.
Bone is roughly a mineral phase of calcium phosphate on an organic collagen matrix, so the two nutrients address different halves of the same tissue. Peptide supplementation supplies matrix amino acids including glycine, proline and hydroxyproline precursors. Human work on peptides reports markers of bone turnover more often than structural endpoints.
Retinoic acid signalling influences osteoblast and osteoclast activity, and very high preformed retinol intakes have been associated with lower bone mineral density in cohort studies. That is an association, reported at intakes well above ordinary supplemental amounts. Worth listing beside a calcium phosphate dose so the whole mineral and vitamin load is read together.
Talk to a doctor before taking Dicalcium Phosphate Dihydrate if any of these apply to you: Lower calcium bioavailability than citrate forms, Primarily a filler, not a calcium supplement. These are flags to check first, not effects Dicalcium Phosphate Dihydrate is known to cause.
Not medical advice. Show the label to your pharmacist.What Dicalcium Phosphate Dihydrate actually does.
This ingredient supplies calcium and phosphate in close to equal amounts, the same two minerals that make up the hard mineral part of bone.
This form dissolves much better in acid, so it starts breaking down in the stomach's acidic environment and slows again once things become less acidic further down.
Calcium gets absorbed two ways: one route that depends on active vitamin D and can get maxed out, and a second route that just lets more through when there's a lot of calcium available in the gut.
The higher a single calcium dose, the smaller the fraction your body actually absorbs, which is why a large daily amount is usually split into smaller doses instead of taken all at once.
Where Dicalcium Phosphate Dihydrate comes from.
It starts as phosphate rock out of the ground. The rock is turned into phosphoric acid, the acid is cleaned up to food standards, and then calcium is added back under careful pH control so the mineral crystallises out with two water molecules locked into it. How hot it is dried decides whether those waters stay, and how finely it is milled decides how it behaves in a tablet press.
From a mineral source, then refined and usually bound to a carrier so the body can take it up.
Mined phosphate rock, mainly apatite, is the phosphorus feedstock. The calcium arrives either from the rock itself or from a separate limestone or lime input.
Rock is digested with sulfuric acid to give phosphoric acid plus gypsum. For food and supplement grades the acid is then purified, typically by solvent extraction, to reduce fluoride and heavy metal content before it goes anywhere near a nutrient stream.
Purified phosphoric acid is neutralised with a calcium source, lime or calcium hydroxide or calcium carbonate, holding the pH in the window where the hydrogen phosphate salt rather than the mono or tri form precipitates. The legacy note on this page names calcium hydroxide plus phosphoric acid, which is one of the routes in use. A carbonate neutraliser is another and neither is presented here as preferable.
The precipitate is filtered and washed to remove residual acid and soluble impurities. Grade separation happens here: feed grade and food or USP grade differ in their contaminant limits, not in the core chemistry.
Drying temperature decides whether the product keeps its two waters of crystallisation or converts toward the anhydrous salt, and it changes the crystal structure seen by X-ray diffraction, which is the point Mafi and colleagues measured in a poultry-science context.
Material is assayed for calcium and phosphorus content and for contaminant limits, then milled or granulated to a target particle size distribution for the compression or blending behaviour a formulator needs.
Getting Dicalcium Phosphate Dihydrate from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- Supplementing a urea-treated forage diet with dicalcium phosphate changed dry matter intake, digestibility and milk composition in the animals studied.Animal study. Wondater et al., 2023 (PLoS One). PMID 37976268 ↗
- Limestone and dicalcium phosphate contribute measurable dietary iron, so the authors argue mineral sources should be counted when the iron content of a feed is calculated.Animal study. Feijo et al., 2024 (Poultry Science). PMID 38442559 ↗
- A mineral soil and dicalcium phosphate mix affected performance measures in sheep fed a urea-treated diet.Animal study. Salo et al., 2026 (Veterinary Medicine and Science). PMID 41306065 ↗
- Drying temperature altered the X-ray diffraction pattern and spatial structure of dicalcium phosphate, so processing conditions change the crystalline material a formulation actually receives.In vitro study. Mafi et al., 2025 (Poultry Science). PMID 41016170 ↗
These are the studies our verdict leans on, chosen from the 4 we read for Dicalcium Phosphate Dihydrate. The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.
